Vogiatzis I, Sdogkos E, Galitsianos I, Koutsambasopoulos K, Stalidou Z
Pacemaker Unit, Department of Cardiology, General Hospital of Veroia, Veroia, Greece.
Hippokratia. 2018 Apr-Jun;22(2):75-79.
During recent years, several recommendations and guidelines regarding cardiac pacing have been published in the literature. However, only a few studies have examined the implementation of these guidelines in clinical practice. The current study aimed to record and evaluate the effects of the mainstream studies, and the experience gathered by all patients who have been followed-up at the pacemaker Unit of Veroia Hospital, which is a secondary care center.
Epidemiological, clinical, and electrocardiographic data were collected and studied for patients with a permanent pacemaker that have been followed-up in our hospital from 2002 to 2017. The total number of patients of the study was 3,902 (2,164 men; 55.45 %) with a mean age of 73.4 ± 12.6 years. Third degree atrioventricular (AV) block was the most common cause of pacing. Dysfunction of the sinus node involved the majority of cases with bradycardia-tachycardia syndrome. At 18 patients, the cause of permanent pacemaker implantation was carotid sinus syndrome and at 13 of them, cardio-vascular type of neurocardiogenic syncope. Dizziness and syncope were the most common symptoms. Dual-chamber pacing was the most common type of pacing, which has been increasing in recent years. In follow-up visits, the most frequent examinations concerned battery condition, as the stimulation and sensing threshold. Reprogramming of the device was required in 1,434 patients (36.75 %), especially during the first year after implantation.
Pacing indications have been unchanged during all the years of the study and have been based on confirmed bradycardia and major symptoms. Reprogramming of the device was needed in an increased number of patients. HIPPOKRATIA 2018, 22(2): 75-79.
近年来,文献中已发表了若干关于心脏起搏的建议和指南。然而,仅有少数研究探讨了这些指南在临床实践中的实施情况。本研究旨在记录和评估主流研究的效果,以及在二级护理中心韦里亚医院起搏器科室接受随访的所有患者所积累的经验。
收集并研究了2002年至2017年在我院接受随访的永久性起搏器患者的流行病学、临床和心电图数据。研究患者总数为3902例(男性2164例;占55.45%),平均年龄为73.4±12.6岁。三度房室传导阻滞是起搏最常见的原因。窦房结功能障碍在大多数心动过缓-心动过速综合征病例中存在。18例患者永久性起搏器植入的原因是颈动脉窦综合征,其中13例为心血管型神经心源性晕厥。头晕和晕厥是最常见的症状。双腔起搏是最常见的起搏类型,近年来呈上升趋势。在随访中,最频繁的检查涉及电池状况以及刺激和感知阈值。1434例患者(36.75%)需要对设备进行重新编程,尤其是在植入后的第一年。
在研究的所有年份中,起搏指征一直未变,且基于确诊的心动过缓和主要症状。需要重新编程的患者数量有所增加。《希波克拉底》2018年,第22卷第2期:75 - 79页。